Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.4088/jcp.08m04905
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: lurasidone, acute schizophrenia, dopamine D2 receptor antagonists, 5-HT2A receptor antagonist, atypical antipsychotics, Brief Psychiatric Rating Scale, PANSS, negative symptoms, extrapyramidal symptoms, drug safety, hospitalized patients, cognitive enhancement, mood improvement, alpha2C-adrenergic receptor, 5-HT7 receptor, 5-HT1A receptor
Open Access status: closed
OpenAlex ID: W1979797229
